Go to
Google
Go to PubMed Go to
Inserm 
Visit Paris5
University
Visit our Building
Research Publications People Programs
Databases
Utilities
Images Presentation
Teaching
Links Collaborations
Contact
Acknowledgments
Latest News Back to first page


Research


Structural Bioinformatics

Get one review (Villoutreix, Curr Prot Pep Science 2002)  here

Structural and theoretical analyses of proteins are central to the understanding of complex molecular mechanisms and are fundamental to the drug discovery process. Computational techniques yield useful insights into an ever-wider range of biomolecular systems. Protein three-dimensional structures and molecular functions can be predicted in some circumstances, while experimental structures can be analyzed in depth via such computational approaches. Non-covalent binding of biomolecules can be understood by considering structural, thermodynamic and kinetic issues, and theoretical simulations of such events can be attempted. The central role of electrostatic interactions with regard to protein function, structure and stability has been investigated and some electrostatic properties can be modeled theoretically. Computer methods thus help to prioritize, design, analyze and rationalize biochemical experiments. We use and develop molecular modeling methods to analyze protein structures, homology modeling, molecular dynamics, Monte Carlo simulations, electrostatics, protein docking.

For instance, we have been using protein docking to investigate the tenase and prothrombinase complexes. You can see Autin L et a., Proteins, 2006, 63:440-50 (PDF here) and Autin L et al., J Thromb Haemost. 2005, 3:2044-56 (here). For MD simulations, investigation of point mutations and electrostatic computations, you can see Miteva M. et al., Nucleic Acids Res. 2005, 33: W372-5 (here) and Miteva M. et al.,  Biophys J. 2004, 86:488-98 (here) 

Protein-protein docking (Tenase complex) by Autin et al.

Virtual Ligand Screening

Get one review (Sperandio, Miteva, Delfaud, Villoutreix, Curr Prot Pep Science 2006)  here
Get another review (Villoutreix, Renault, Lagorce, Sperandio, Montes, Miteva, Curr Prot Pep Science 2007)  here

In today's research environment, a wealth of experimental structural data are available and the number of therapeutically relevant macromolecular structures is growing rapidly. This, coupled with the huge amount of small non-peptide potential drug candidates on hand highlight the need of using computer-aided techniques for the efficient identification and optimization of novel hit compounds. Virtual (or in silico) ligand screening based on the three-dimensional structure of macromolecular targets (SB-VLS) is firmly established as an important approach to identify chemical entities that have a high likelihood of binding to a target molecule to elicit desired biological responses. When the 3D structure of the receptor is not known, it is possible to use in some cases ligand-based in silico screening methods. For most projects, a compound collection has to be created. These small molecules should have acceptable ADME/tox properties. In our team, we work with ADME/tox methods and virtual screening. We attempt to optimize some of these methods and we apply such computations on several important therapeutic targets. We have recently identified many new hits in the area of cancer, allergy, coagulation...

Combining VLS and experimental HTS

You can see some recent studies from our group for ADME/tox, Miteva et al., 2006, Nucleic Acids Res. 2006, 34:W738-44 (here) and for VLS, Miteva et al., J Med Chem. 2005, 48:6012-22 (here).